A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
NCT07124208
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DEVICE:
Biophoton Generators
Sponsor
First Institute of All Medicines